Pei Liu

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 4

Top Topics

Top Venues

Clinical pharmacokinetics

Pharmacology research & perspectives

This page only lists publications with an associated author ORCID identifier.

Publications

Xuening Li, Miwa Haranaka, Hui Li, Pei Liu, Huijun Chen, Stefan Klein, Stefanie Reif, Klaus Francke, Christian Friedrich, Kazuhito Okumura
P2X3 Receptor Antagonist Eliapixant in Phase I Clinical Trials: Safety and Inter-ethnic Comparison of Pharmacokinetics in Healthy Chinese and Japanese Participants. Clinical pharmacokinetics (2024)
Xuening Li, Miwa Haranaka, Hui Li, Pei Liu, Huijun Chen, Stefan Klein, Stefanie Reif, Klaus Francke, Christian Friedrich, Kazuhito Okumura
P2X3 Receptor Antagonist Eliapixant in Phase I Clinical Trials: Safety and Inter-ethnic Comparison of Pharmacokinetics in Healthy Chinese and Japanese Participants. Clinical pharmacokinetics 63 (6) (2024)
Xuening Li, Miwa Haranaka, Hui Li, Pei Liu, Huijun Chen, Stefan Klein, Stefanie Reif, Klaus Francke, Christian Friedrich, Kazuhito Okumura
P2X3 Receptor Antagonist Eliapixant in Phase I Clinical Trials: Safety and Inter-ethnic Comparison of Pharmacokinetics in Healthy Chinese and Japanese Participants. Clinical pharmacokinetics 63 (6) (2024)
Zhili Dong, Kensei Hashizume, Frauke Friedrichs, Pei Liu, Toshiaki Tanaka, Yuqin Liao
Pharmacokinetics and pharmacodynamics of the factor XIa-inhibiting antibody osocimab in healthy male East Asian volunteers: Results from two phase 1 studies. Pharmacology research & perspectives 12 (5) (2024)